G1 Therapeutics to Report Fourth Quarter and Full-Year 2017 Financial Results on February 21, 2018

RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2018 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (NASDAQ:GTHX), a clinical-stage oncology company, today announced that fourth quarter and full-year 2017 financial results will be reported on Wednesday, February 21, 2018, after the close of U.S. financial markets. The company will host a webcast and conference call at 4:30 p.m. EST to discuss the financial results and provide an update on its corporate activities and product pipeline.

The live call may be accessed by dialing 866-763-6020 (domestic) or 210-874-7713 (international), and entering the conference code: 9679925. A live and archived webcast of the call will be available in the Investors section of G1’s website at www.g1therapeutics.com.

About G1 Therapeutics

G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer. G1’s two clinical assets, trilaciclib and G1T38, are CDK4/6 …

Full story available on Benzinga.com

Source-Click here

Leave a Reply

Your email address will not be published. Required fields are marked *